Compritol® 888 ATO Gattefosse India Pvt Ltd

compritol 888 ato  Conclusion: The present study has concluded that Compritol ATO 888 can be used as matrix-forming agent to control the release of a highly water soluble drug  Estimating in vivo drug release from a new theophylline Compritol® 888 ATO matrix formulation using appropriate biorelevant test methods Paper

pectin20 % compritol ATO 888 and 60 % pectin40 % compritol ATO 888 combinations were used for the outer shell compression coating Coating forces were 20 Abstract: The sustained release tablets of diclofenac sodium was prepared with Compritol® 888 ATO as a lipid matrix and the in-vitro dissolution

Metformin hydrochloride sustained-release solid dispersions were prepared by the solvent evaporation and closed melt method, using compritol 888 ATO Metformin hydrochloride sustained-release solid dispersions were prepared by the solvent evaporation and closed melt method, using compritol 888 ATO